Among these mutations, two truncating mutations were found in 15 BRCA1/2-negative high-risk breast cancer families by whole-exome sequencing, and another two were found in 438 validating BRCA1/2-negative breast cancer families screened over the entire coding region by Sanger sequencing. This evidence concerns the gene BRCA1 and breast cancer.